Details
Stereochemistry | ACHIRAL |
Molecular Formula | C15H16O2 |
Molecular Weight | 228.2863 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC2=C(C=C1)C=C(CCC(C)=O)C=C2
InChI
InChIKey=BLXXJMDCKKHMKV-UHFFFAOYSA-N
InChI=1S/C15H16O2/c1-11(16)3-4-12-5-6-14-10-15(17-2)8-7-13(14)9-12/h5-10H,3-4H2,1-2H3
Molecular Formula | C15H16O2 |
Molecular Weight | 228.2863 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:47:12 UTC 2023
by
admin
on
Fri Dec 15 15:47:12 UTC 2023
|
Record UNII |
LW0TIW155Z
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
M01AX01
Created by
admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
|
||
|
FDA ORPHAN DRUG |
255207
Created by
admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
|
||
|
NCI_THESAURUS |
C54679
Created by
admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
|
||
|
WHO-VATC |
QM01AX01
Created by
admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
|
||
|
NDF-RT |
N0000000160
Created by
admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
|
||
|
NDF-RT |
N0000175722
Created by
admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
|
||
|
NCI_THESAURUS |
C257
Created by
admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
|
||
|
NDF-RT |
N0000175721
Created by
admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
|
||
|
LIVERTOX |
NBK548909
Created by
admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000092274
Created by
admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
|
PRIMARY | |||
|
Nabumetone
Created by
admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
|
PRIMARY | |||
|
LW0TIW155Z
Created by
admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
|
PRIMARY | |||
|
7443
Created by
admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
|
PRIMARY | |||
|
31448
Created by
admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
|
PRIMARY | RxNorm | ||
|
1449518
Created by
admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
|
PRIMARY | |||
|
C47627
Created by
admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
|
PRIMARY | |||
|
SUB09107MIG
Created by
admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
|
PRIMARY | |||
|
m7698
Created by
admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
|
PRIMARY | Merck Index | ||
|
DB00461
Created by
admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
|
PRIMARY | |||
|
42924-53-8
Created by
admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
|
PRIMARY | |||
|
C035605
Created by
admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
|
PRIMARY | |||
|
4855
Created by
admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
|
PRIMARY | |||
|
CHEMBL1070
Created by
admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
|
PRIMARY | |||
|
4409
Created by
admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
|
PRIMARY | |||
|
DTXSID4045472
Created by
admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
|
PRIMARY | |||
|
7245
Created by
admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
|
PRIMARY | |||
|
NABUMETONE
Created by
admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
|
PRIMARY | |||
|
LW0TIW155Z
Created by
admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
|
PRIMARY | |||
|
76252
Created by
admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
|
PRIMARY | |||
|
758623
Created by
admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
|
PRIMARY | |||
|
1863
Created by
admin on Fri Dec 15 15:47:12 UTC 2023 , Edited by admin on Fri Dec 15 15:47:12 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (HPLC)
EP
|
||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (HPLC)
USP
|
||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
BINDER->LIGAND |
BINDING
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT |
URINE
|
||
|
METABOLITE -> PARENT |
URINE
|
||
|
METABOLITE ACTIVE -> PARENT |
has anti-inflammatory activity in animals; more potent inhibitor of prostaglandin synthesis than nabumetone
MAJOR
PLASMA
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
UNSPECIFIED
EP
|
||
|
IMPURITY -> PARENT |
UNSPECIFIED
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
UNSPECIFIED
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
UNSPECIFIED
EP
|
||
|
IMPURITY -> PARENT |
UNSPECIFIED
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
|
|||
Volume of Distribution | PHARMACOKINETIC |
|
|
|||
Tmax | PHARMACOKINETIC |
|
AT STEADY-STATE |
|
||
Tmax | PHARMACOKINETIC |
|
DOSE |
|
||